Growth Metrics

Iradimed (IRMD) Dividends payables (2023)

Iradimed (IRMD) reported Dividends payables of $8.0 million for Q4 2023.

Iradimed (IRMD) has 1 years of Dividends payables data on file, last reported at $8.0 million in Q4 2023.

  • Quarterly Dividends payables changed N/A year-over-year to $8.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $8.0 million (changed N/A YoY) and the FY2023 annual result came in at $8.0 million, changed N/A from the prior year.
  • Dividends payables steadied at $8.0 million in Q4 2023 per IRMD's latest filing.
  • Across five years, Dividends payables topped out at $8.0 million in Q4 2023 and bottomed at $8.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.10 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 337.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Iradimed 1.17 Bn 1.11 Bn 16.81 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 7.98 Mn